Turnover: ()

Country: France

The PSD group was founded in 2017 and today brings together 4 major groups: Pharma Group Santé, G1000 Pharmacies, Nepenthès and Optipharm, bringing together over 2,000 pharmacies across France.

Cumulative annual sales amount to 3 billion euros. It also has its own brand (NEP), and an accredited training organization (Pharmacade).


Optipharm boosts Pharma Santé Développement's growth 21/01/2022

  • Pharma Santé Développement (PSD) acquires Optipharm.
  • The acquisition adds a further 1,200 members, mainly in western France.
  • PSD doubles in size to 2,500 pharmacy customers.
  • PSD now accounts for almost 10% of the French pharmacy market.
  • The target's founders are stepping down, while the members remain shareholders.
  • The acquisition was financed by a mix of equity and debt, with refinancing of the LBO debt.

Studies mentioning this company

The pharmacy market - France

Other companies mentioned: